ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat lung cancer: trial tests promising drug duo
Disease control OngoingThis study is for people with advanced non-small cell lung cancer that has worsened after standard immunotherapy and chemotherapy. It compares a new two-drug combination (ceralasertib plus durvalumab) against the current standard chemotherapy (docetaxel). The main goal is to see …
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 04, 2026 05:21 UTC
-
New shot offers hope for easier lung cancer treatment
Disease control OngoingThis study is testing a new, easier-to-administer injection (a shot under the skin) for a lung cancer drug called amivantamab, which is given with another drug called lazertinib. It aims to see if this new method works as well as the standard intravenous (IV) infusion but takes l…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC